BackSunny Pharmtech Overview

Sunny Pharmtech Accounts Payable

Track Sunny Pharmtech's accounts payable ($3.1M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$3.11M
↓ 90.11% YoYΔ $-28.30M vs prior year quarter

Peer trimmed avg / median

Loading

Sunny Pharmtech Accounts Payable History

Loading

Sunny Pharmtech vs. peers: Accounts Payable Comparison

Loading

Sunny Pharmtech Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Sunny Pharmtech (6676.TWO) FAQ

Sunny Pharmtech (6676.TWO) currently reports a accounts payable of $3.1M as of June 2026. That compares with $31M in the prior-year period — down 90.1% year over year. Use the charts on this page to explore Sunny Pharmtech's accounts payable history and peer comparisons.

Sunny Pharmtech's accounts payable decreased from $31M to $3.1M — a 90.1% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Sunny Pharmtech reported $3.1M in accounts payable as of June 2026. That compares with $31M in the prior-year period — down 90.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $3.1M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Sunny Pharmtech, and consider following 6676.TWO for alerts when major investors trade the stock.

Sunny Pharmtech is classified in the Healthcare sector. On accounts payable, it currently shows $3.1M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 6676.TWO with unrelated industries.